Diagnostic Criteria
Rosner Rebuttal
Central Nervous System

Compare Symptoms
Chiari I Malformation
Cervical Spinal Stenosis
Low Blood Pressure
MRI Requirements
Patient Testimonials

Dr. Heffez Information
Introduction to NFRA
NFRA Symposiums

Subgroups in FM
New Dimensions in FM
Other Abstracts

Awareness Pin
Gifts and Memorials
Calendar of Events
Resources & Web Links
Patient Organizations

www.fmaware.org
www.fmpartnership.org

New Dimensions in Fibromyalgia

September 14-15, 1997
Portland, Oregon

  Selected Speakers and Their Abstracts

	Peter Rowe, MD, Johns Hopkins Medical Neurally Mediated Hypotension in Fibromyalgia Patients
	Michael Rosner, MD, University of Alabama Decompression of Craniovertebral Stenosis Leads to Improvement in FMS and CFIDS Symptoms
	Ron Kramis, Ph.D., R.S. Dow Neurological Sciences Fibromyalgia: Non-nociceptive Aspects of Persistent Musculoskeletal Pain
	Alice Larson, Ph.D., University of Minnesota Possible Role of NGF in the Etiology of Fibromyalgia
	Jay Goldstein, MD, Orange, California Pathophysiology of Neurosomatic Disorders: A Summary
	Stanley Pillimer, MD, National Institutes of Health Epidemiological Considerations in Identifying Cases of Fibromyalgia Syndrome
	Robert Bennett, MD, Oregon Health Sciences University Diagnosis and Classification of Fibromyalgia: Where do we draw the line?
	Daniel Clauw, MD, Georgetown University Fibromyalgia is More Than Pain
	Gail Adler, MD, Harvard Medical School, Brigham & Women's Hospital Can Neuroendocrine Abnormalities Help Define Fibromyalgia Syndrome?
	Muhammad Yunus, MD, University of Illinois at Peoria Genetic Factors in Fibromyalgia Syndrome
	I. Jon Russell, M.D., Ph.D., University of Texas Health Science Center at San Antonio Investigative Pathways of Diagnosis

National Fibromyalgia Research Association
PO Box 500, Salem, OR 97302